India, Aug. 25 -- Aurigene Pharmaceutical Services Ltd, a wholly owned subsidiary of Dr Reddy's Laboratories, has entered into a long-term manufacturing and supply agreement with an undisclosed global pharmaceutical company.
Under the agreement, Aurigene will undertake commercial drug-product manufacturing and supply across a diversified portfolio for markets including the US, Europe, Canada and emerging economies.
The company, which operates as a contract research, development and manufacturing organisation (CRDMO), said the identity of the partner has not been disclosed due to confidentiality obligations under the agreement.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....